NEW YORK (Reuters Health) - People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study. The early trials, known as "Phase 1," are often the first time a new drug is given to humans and the goal of the studies is to test for side effects and acceptable dosage levels. Participation rarely benefits the person's health. One of the new report's authors says it's well known that people taking part in early trials confuse the research for medical care, but it goes beyond that. ... read more..
Strutting the Catwalk in Red, Stars Promote 'The Heart Truth'
THURSDAY, Feb. 9 (HealthDay News) -- The star power gathered on the runway was impressive and so were the red-hot designer frocks, all on display at the 10th annual "The Heart Truth" Red Dress Collection fashion show, held in New York City on Wednesday night. read more..
No comments:
Post a Comment